The addition of sotatercept, an activin-signaling inhibitor, to background therapy results in a lower risk for clinical worsening among adults with pulmonary arterial hypertension (PAH) who were ...

The use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) before surgery rose 16-fold among patients undergoing metabolic and bariatric surgery from 2020 to 2024.

Familial clustering was identified in primary hyperparathyroidism, as first-degree relatives were at higher risk than control patients.

Approximately 29% of patients with acute COVID-19 infection developed long COVID, with female sex, diabetes, reinfection, and hospitalization predicting delayed recovery.

High intake of sugar-sweetened beverages (SSBs) and low- or non-sugar-sweetened beverages (LNSSBs) is associated with an increased risk for incident metabolic dysfunction-associated steatotic liver ...

Use of ambient artificial intelligence (AI) scribes is associated with a reduction in burnout and cognitive task load among clinicians.

Transgender patients with heart failure who receive treatment at urban hospitals, compared with rural hospitals, have worse outcomes.

We know it can be difficult to keep up with emerging research, conference news, and guideline updates. Enter the Grand Roundup: a hyper-focused, curated newsletter on clinical topics that matter most ...

The Food and Drug Administration has approved Enoby, a biosimilar to Prolia, and Xtrenbo, a biosimilar to Xgeva.

There is lower risk for mortality in patients with cardio-renal-metabolic multimorbidity who maintain hematologic parameters within optimal ranges.

Higher glycemic load was associated with elevated postprandial glucose on the basis of meal timing among patients without diabetes.